LEADER 00842nam0-22003011i-450-
001 990002895340403321
035   $a000289534
035   $aFED01000289534
035   $a(Aleph)000289534FED01
035   $a000289534
100   $a20000920d1983----km-y0itay50------ba
101 0 $aITA
200 1 $aAnnuario di statistiche demografiche$e1981$fIstituto centrale di statistica
210   $aRoma$cPoligrafico campano$d1983
215   $a160 p.$d25 cm
300   $aVol. 30
300   $aTomo 1
610 0 $aItalia$astatistiche demografiche$a1981
676   $a306.8
700  1$aIstat$0445627
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990002895340403321
952   $aCDI-SD30a-83-Pos-58$b2207$fMAS
959   $aMAS
996   $aAnnuario di statistiche demografiche$9466662
997   $aUNINA
DB    $aING01

LEADER 01015nam  2200361   450 
001 9910317795803321
005 20221012201723.0
010   $a1-83881-498-1
010   $a1-78923-623-1
035   $a(CKB)4970000000100126
035   $a(NjHacI)994970000000100126
035   $a(EXLCZ)994970000000100126
100   $a20221012d2018      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aAnticoagulant drugs /$fedited by Mojca Boz?ic? Miljkovski
210  1$aLondon, England :$cIntechOpen,$d[2018]
210  4$dİ2018
215   $a1 online resource (120 pages)
311   $a1-78923-622-3 
606   $aAnticoagulants (Medicine)
615  0$aAnticoagulants (Medicine)
676   $a615.718
702   $aBoz?ic?-Mijovski$b Mojca$cDr.,
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910317795803321
996   $aAnticoagulant Drugs$92033110
997   $aUNINA